Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Career Stage

Topic Area

Eligible Country

Sponsor Type

Award Amount

Eligibility

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Frontier Health Markets APS

US Agency for International Development

The U.S. Agency for International Development’s (USAID) Office of Population and Reproductive Health (PRH) is pleased to announce the Frontier Health Markets (FHM) Annual Program Statement (APS) which aims to help achieve global U.S. Government (USG) health priorities and commitments, specifically related to preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious diseases. FHM will improve the functioning of local health markets and will support the effective engagement and systemic inclusion of the private sector to advance voluntary family planning, maternal, newborn and child health, malaria, TB, and HIV/AIDS outcomes. FHM will leverage existing evidence and best practices, as well as catalyze new ideas, forge partnerships, and innovative approaches to foster the introduction, scale up, and sustainability of quality healthcare delivery in the private sector to achieve our ambitious global health targets and help enhance countries’ ability to fortify and diversify healthcare delivery.

The design of FHM reflects the evolution in USAID’s private sector programming with a greater emphasis on strengthening health market systems. It is designed to enhance countries’ ability to fortify and diversify healthcare delivery and to ensure that USAID’s investments are tailored to country contexts and needs. Fundamental to FHM’s design is the premise that market-based approaches can lead to greater scale and sustainability of development outcomes. This is based on the assumption that as long as a business case or market system exists for a good or service, it has a greater likelihood of sustaining itself without external support. FHM also recognizes that countries which received USAID support have different local contexts, from a business and health policy point of view, as well as a regulatory lens, that require unique support.

FHM will also include a greater focus on building the technical capacity, sustainability, and resilience of local partner institutions, while maintaining an emphasis on advancing the scale-up of evidence-based approaches and interventions. FHM will aim to forge new partnerships with a significant number of development actors and diversify USAID’s partner base through concentrated efforts to engage the local private sector at the country level for state-of-the-art technical expertise, local market intelligence, and service delivery.

This document is an umbrella APS and will not solicit concept papers or applications. Prospective applicants will be provided a fair opportunity to develop and submit competitive concept papers to USAID for potential funding via Rounds under this APS.

Closing Date: February 24, 2028

Specialties

International Opportunities

Medical - Clinical Science

Medical

Social Sciences

Eligibility Requirements

U.S. and non-U.S. public, private, for-profit, and nonprofit organizations, as well as institutions of higher education, public international organizations, and non-governmental organizations, are eligible to submit a concept paper under each Round(s) of the APS. Further, the organization must be a legally recognized, organizational entity under applicable law, legally registered in a country within the geographic code 937 (“the United States, the recipient country, and developing countries other than advanced developing countries, but excluding any country that is a prohibited source,” per ADS 310.3.1.1).

Sponsor Details

Sponsor Institute/Organizations: US Agency for International Development

Sponsor Type: Government/Federal

Address: NA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity